Open Access

A population‑based study of outcomes in patients with surgically resected non‑small cell lung cancer with anaplastic lymphoma kinase‑rearranged mutations: A matched‑pair study

  • Authors:
    • Masaharu Inagaki
    • Hideo Ichimura
    • Shingo Usui
    • Kesato Iguchi
    • Osamu Ishibashi
    • Ryota Nakamura
    • Yoshihisa Inage
    • Hisashi Suzuki
    • Moriyuki Kiyoshima
    • Koichi Kamiyama
    • Masaki Kimura
    • Susumu Yoshida
    • Mitsuaki Sakai
    • Naohiro Kobayashi
    • Kinya Furukawa
    • Hiroaki Satoh
    • Nobuyuki Hizawa
    • Yukio Sato
  • View Affiliations

  • Published online on: November 19, 2020     https://doi.org/10.3892/mco.2020.2173
  • Article Number: 11
  • Copyright: © Inagaki et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study aimed to evaluate clinical outcomes in patients with surgically resected non‑small cell lung cancer (NSCLC) with anaplastic lymphoma kinase (ALK)‑rearranged mutations. A matched‑pair analysis in completely resected ALK‑rearranged NSLC patients and those with neither ALK nor epidermal growth factor receptor (EGFR) mutations diagnosed at 11 institutes was performed between April 2008 and March 2019. A total of 51 patients with surgically resected ALK‑rearranged NSCLC were included. Women constituted 68.6%, and smokers 29.4%. The median age was 65 years. In matched‑pair analysis, disease‑free survival and overall survival did not differ between patients with ALK‑rearranged mutations and those without mutations. Post‑recurrence survival in patients with ALK mutations was longer than that of patients with neither ALK nor epidermal growth factor receptor mutations. ALK genetic testing should be performed, even in elderly patients with NSCLC. Favorable prognosis might be expected after appropriate treatment for patients with recurrent ALK‑mutated disease.

Related Articles

Journal Cover

January-2021
Volume 14 Issue 1

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Inagaki M, Ichimura H, Usui S, Iguchi K, Ishibashi O, Nakamura R, Inage Y, Suzuki H, Kiyoshima M, Kamiyama K, Kamiyama K, et al: A population‑based study of outcomes in patients with surgically resected non‑small cell lung cancer with anaplastic lymphoma kinase‑rearranged mutations: A matched‑pair study. Mol Clin Oncol 14: 11, 2021
APA
Inagaki, M., Ichimura, H., Usui, S., Iguchi, K., Ishibashi, O., Nakamura, R. ... Sato, Y. (2021). A population‑based study of outcomes in patients with surgically resected non‑small cell lung cancer with anaplastic lymphoma kinase‑rearranged mutations: A matched‑pair study. Molecular and Clinical Oncology, 14, 11. https://doi.org/10.3892/mco.2020.2173
MLA
Inagaki, M., Ichimura, H., Usui, S., Iguchi, K., Ishibashi, O., Nakamura, R., Inage, Y., Suzuki, H., Kiyoshima, M., Kamiyama, K., Kimura, M., Yoshida, S., Sakai, M., Kobayashi, N., Furukawa, K., Satoh, H., Hizawa, N., Sato, Y."A population‑based study of outcomes in patients with surgically resected non‑small cell lung cancer with anaplastic lymphoma kinase‑rearranged mutations: A matched‑pair study". Molecular and Clinical Oncology 14.1 (2021): 11.
Chicago
Inagaki, M., Ichimura, H., Usui, S., Iguchi, K., Ishibashi, O., Nakamura, R., Inage, Y., Suzuki, H., Kiyoshima, M., Kamiyama, K., Kimura, M., Yoshida, S., Sakai, M., Kobayashi, N., Furukawa, K., Satoh, H., Hizawa, N., Sato, Y."A population‑based study of outcomes in patients with surgically resected non‑small cell lung cancer with anaplastic lymphoma kinase‑rearranged mutations: A matched‑pair study". Molecular and Clinical Oncology 14, no. 1 (2021): 11. https://doi.org/10.3892/mco.2020.2173